Affordability & Price Transparency
Expert articles and analysis related to affordability & price transparency.
AI Summary — Last 30 Days
Affordability and transparency are becoming more operationally consequential for VBC as CMS tightens prior authorization reporting across MA, Medicaid managed care, and ACA Marketplace plans, while 2025 data show at least 1 in 8 standard PA requests are denied—raising pressure on risk-bearing providers to manage access friction, documentation burden, and member experience more proactively (KFF prior authorization analysis). At the same time, the 2025 reconciliation law’s limits on Medicaid state directed payments could reduce hospital-directed Medicaid funding in at least 37 states, creating a margin shock that may accelerate provider interest in accountable care, population health infrastructure, and payer-provider alignment—but also intensify disputes over whether VBC can offset lost supplemental payment streams (KFF Medicaid directed payments analysis). Medicare Advantage remains strategically unsettled, with large insurers pulling back even as players like SCAN and nontraditional entrants test contrarian growth strategies, signaling that affordability pressure is shifting competition toward narrower risk selection, administrative efficiency, and differentiated care management rather than simple enrollment expansion.
Related Articles
A tragedy of epic proportions looms for healthcare
Garrett Hardin popularized the idea of a tragedy of the commons in a 1968 Science essay carrying that title.[1] It describes a situation in which individuals with unlimited access to a public resource...
The rise and consequences of PBM vertical integration
Decades ago, PBMs were independent operators, but now, the biggest ones are vertically integrated with healthcare conglomerates.
What appeals court 340B rebate decision means for federal rebates
An appeals court barred 340B rebate programs by drug manufacturers, among recent legal developments. The case could have ramifications for federal 340B rebates. On July 21, the U.S. Court of Appeals f...
How Has ACA Marketplace Enrollment Changed Across States in 2026?
Following several years of rapid enrollment growth in the Affordable Care Act (ACA) Marketplaces that corresponded with temporary enhanced premium tax credits, enrollment fell for the first time in se...
The Limits of Disclosure and the Power of the Outside Option: A Case for External Reference Pricing in Healthcare
By DAVID INTROCASO & ADAM CUNNINGHAM For over a decade, federal healthcare policy has operated on a foundational premise: if hospital prices are made visible, market discipline will inevitably follow....
Drug pricing and the IRA: Tracking the government's negotiation power
Drug pricing and the IRA: Tracking the government's negotiation power Endpoints News
Brand Drugmakers’ Patent Abuse Is Raising Americans’ Healthcare Costs by Billions Each Year
Brand Drugmakers’ Patent Abuse Is Raising Americans’ Healthcare Costs by Billions Each Year AHIP
The $48B Payor Nobody Contracts With
Executive Summary While You Were Fighting the 800 Pound Managed Care Gorilla, a New Payor Walked In Every hospital CFO can recite their payor mix from memory: Medicare, Medicaid, commercial, self-pay....
Emerging 2026 ACA Data: Enrollment Drops 12% as Relative Risk Rises 6.3%
New data show a smaller, higher-risk ACA individual market emerging after enhanced premium tax credits expired. In Wakely’s new white paper, 2026 Individual Market Risk Pool Considerations: Emerging D...